MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 25 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $238,320 | -34.7% | 207,235 | +48.0% | 0.07% | -6.3% |
| Q3 2022 | $365,000 | -45.6% | 139,986 | -54.7% | 0.08% | -41.5% |
| Q2 2022 | $671,000 | -55.2% | 309,178 | -3.7% | 0.14% | -29.7% |
| Q1 2022 | $1,497,000 | -31.0% | 321,187 | -10.2% | 0.19% | -46.4% |
| Q4 2021 | $2,168,000 | +52.7% | 357,790 | +81.4% | 0.36% | +95.6% |
| Q3 2021 | $1,420,000 | -59.9% | 197,184 | -64.9% | 0.18% | -54.9% |
| Q2 2021 | $3,542,000 | – | 562,200 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |